In vitro storage characteristics of platelet concentrates suspended in 70% SSP+TM additive solution versus plasma over a 14-day storage period

Vox Sanguinis

Volumn 101, Issue 2, 2011, Pages 112-121

  Saunders, C ^a   Rowe, G ^a   Wilkins, K ^b   Holme, S ^c   Collins, P ^d  

^a Welsh Blood Service   (United Kingdom)

^b Pall Medical   (United Kingdom)

^c Pall Medical ^*  (United States)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Additive solution; Extended storage; Platelets; SSP+

Indexed keywords

CHEMICAL COMPOUND; LIPOCORTIN 5; PADGEM PROTEIN; PLATELET ADDITIVE SOLUTION; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; PH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE LIFESPAN; THROMBOCYTE METABOLISM; THROMBOCYTE PRESERVATION; THROMBOCYTE STRUCTURE; THROMBOCYTE VOLUME;

BLOOD PLATELETS; BLOOD PRESERVATION; HUMANS; ORGAN PRESERVATION SOLUTIONS; PLATELET ACTIVATION; PLATELET-RICH PLASMA;

EID: 79960242992     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01468.x     Document Type: Article

References (36)

1. de Wildt-Eggen J, Nauta S, Schrijver JG, et al.: Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study. Transfusion 2000; 40:398-403.
2. Kerkhoffs JH, Eikenboom JC, Schipperus MS, et al.: A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. Blood 2006; 108:3210-3215.
3. Prowse C: Controlling the blood-borne spread of human prion disease. ISBT Science Series 2006; 1:21-24.
4. van der Meer PF, Pietersz RBI, Tiekstra MJ, et al.: WBC-reduced platelet concentrates from pooled buffy coats in additive solution: an evaluation of in vitro and in vivo measures. Transfusion 2001; 41:917-922.
5. Cardigan R, Sutherland J, Garwood M, et al.: In vitro function of buffy coat-derived platelet concentrates stored for 9days in CompoSol, PAS II or 100% plasma in three different storage bags. Vox Sang 2008; 94:103-112.
6. Ringwald J, Haager B, Krex D, et al.: Impacct of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets. Transfusion 2006; 46:942-948.
7. Hornsey VS, McColl K, Drummond O, et al.: Extended storage of platelets in SSP+ platelet additive solution. Vox Sang 2006; 91:41-46.
8. van der Meer PF, Pietersz RNI, Reesink HW: Storage of platelets in additive solution for up to 12days with maintenance of good in-vitro quality. Transfusion 2004; 44:204-1211.
9. Sweeney J, Kouttab N, Holme S, et al.: Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution. Transfusion 2006; 46:835-840.
10. Li J, Xia Y, Bertino AM, et al.: The mechanism of apoptosis in human platelets during storage. Transfusion 2000; 40:1320-1329.
11. Sandgren P, Mayaudon V, Payrat J-M, et al.: Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over. Vox Sang 2010; 98:415-422.
12. Sandgren P, Callaert M, Shanwell A, et al.: Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study. Transfusion 2008; 48:688-696.
13. Kilkson H, Holme S, Murphy S: Platelet metabolism during storage of platelet concentrates at 22°C. Blood 1984; 64:406-414.
14. Girotti S, Ferri E, Loredana Cascione M, et al.: Methodological problems of direct bioluminescent ATP assay in platelets and erythrocytes. J Biolumin Chemilumin 1989; 4:594-601.
15. Maurer-Spurej E, Chipperfield K: Past and future approaches to assess the quality of platelets for transfusion. Transfus Med Rev 2007; 21:295-306.
16. Holme S, Moroff G, Murphy S: A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Transfusion 1998; 38:31-40.
17. Verhoeven AJ, Verhaar R, Gouwerok EGW, et al.: The mitochondrial membrane potential in human platelets: a sensitive parameter for platelet quality. Transfusion 2005; 45:82-89.
18. James V (ed): Guidelines for the Blood Transfusion Services in the United Kingdom, 7th edn. London, The Stationery Office, 2005.
19. Murphy S: The efficacy of synthetic media in the storage of human platelets for transfusion. Transfus Med Rev 1999; 13:153-163.
20. Vinay P, Cardoso M, Tejedor A, et al.: Acetate metabolism during hemodialysis: metabolic considerations. Am J Nephrol 1987; 7:337-354.
21. Diedrich B, Sandgren P, Jansson B, et al.: In vitro and in vivo effects of potassium and magnesium on storage up to 7days of apheresis platelet concentrates in platelet additive solution. Vox Sang 2008; 94:96-102.
22. Cardigan R, Turner C, Harrison P: Current methods of assessing platelet function: relevance to transfusion medicine. Vox Sang 2005; 88:153-163.
23. Holme S, Murphy S: Quantitative measurements of platelet shape by light transmission studies; application to storage of platelets for transfusion. J Lab Clin Med 1978; 92:53-64.
24. Murphy S, Rebulla P, Bertolini F, et al.: In vitro assessment of the quality of stored platelet concentrates. Transfus Med Rev 1994; 8:29-36.
25. Ushiyama S, Laue TM, Moore KL, et al.: Structural and functional characterization of monomeric soluble P-selectin and comparison with membrane P-selectin. J Biol Chem 1993; 268:15229-15237.
26. Dunlop LC, Skinner MP, Bendall LJ, et al.: Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med 1992; 175:1147-1150.
27. Keuren JFW, Cauwenberghs S, Heeremans J, et al.: Platelet ADP response deteriorates in synthetic storage media. Transfusion 2006; 46:204-212.
28. Dijkstra-Tiekstra MJ, Pietersz RNI, Huijgens PC: Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters. Vox Sang 2004; 87:257-263.
29. Wagner SJ, Vassallo R, Skripchenko A, et al.: The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage. Transfusion 2008; 48:1072-1080.
30. Curvers J, de Wildt-Eggen J, Heeremans J, et al.: Flow cytometric measurement of CD62P (P-selectin) expression on platelets: a multicenter optimization and standardization effort. Transfusion 2008; 48:1439-1446.
31. Shapira S, Friedman Z, Shapiro H, et al.: The effect of storage on the expression of platelet membrane phosphatidylserine and the subsequent impact on the coagulation function of stored platelets. Transfusion 2000; 40:1257-1263.
32. Zwaal RFA, Schroit AJ: Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89:1121-1132.
33. Kile BT: The role of the intrinsic apoptosis pathway in platelet life and death. J Thromb Haemost 2009; 7(Suppl. 1):214-217.
34. Kroemer G, Galluzzi L, Brenner C: Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007; 87:99-163.
35. Perrotta PL, Perrotta CL, Snyder EL: Apoptotic activity in stored human platelets. Transfusion 2003; 43:526-535.
36. Li J, Lockerbie O, de Korte D, et al.: Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology. Transfusion 2005; 45:920-926.